Basic Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6079-6092
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6079
Figure 6
Figure 6 miR-588/cylindromatosis axis regulates cisplatin resistance of gastric cancer cells. A: Cell viability detected by CCK-8 assay; B: Cell apoptosis analyzed by flow cytometry. The SGC7901 cells were treated with cisplatin (DDP), or co-treated with DDP and miR-588 inhibitor with or without cylindromatosis siRNA. Data shown are the mean ± SD. bP < 0.01. DDP: Cisplatin; CYLD: Cylindromatosis.